Investigating the Next Wave of Innovation to Help People with Hemophilia

Watch below.
Watch below.
Pfizer is proud of its commitment to advancing hemophilia care for more than 40 years, dating back to the introduction of recombinant therapies.
Pfizer is proud of its commitment to advancing hemophilia care for more than 40 years, dating back to the introduction of recombinant therapies.
Despite significant advancements in hemophilia treatments over the past several decades, balancing management of the disorder while maintaining regular day-to-day activities remains a challenge.
Despite significant advancements in hemophilia treatments over the past several decades, balancing management of the disorder while maintaining regular day-to-day activities remains a challenge.
Lyme disease is the most common vector-borne illness in the United States.
Lyme disease is the most common vector-borne illness in the United States.
Migraine, a debilitating neurological disorder, affects over a billion people globally. The cause of migraine remains an active area of research.
Migraine, a debilitating neurological disorder, affects over a billion people globally. The cause of migraine remains an active area of research.
Learn how changing climate conditions are affecting the spread of Lyme Disease and 5 facts you need to know about the disease.
Learn how changing climate conditions are affecting the spread of Lyme Disease and 5 facts you need to know about the disease.